EMV Capital — Full Portfolio

Cytovale develops microfluidic deformability cytometry technology for immune response diagnostics, with a focus on early detection and diagnosis in hospital settings.

BiotechDigital HealthHealthtechMedical DevicesSan Francisco, US

Ajay Shah(Co-founder & CEO)inHenry Tse(Co-founder & Chief Technology Officer)inDino DiCarlo(Director, Promoter)

BoardLindy Fishburne(Director)inJack Fuchs(Director, Promoter)in

Co-investorsAlumni VenturesBasecamp FundBlackhorn VenturesBreakout LabsBreakout VenturesIT-Farm Corporation+3 more

AIVIVO develops drug discovery solutions at the organism level, focusing on accelerating pharmaceutical development processes.

AI & Machine LearningBiotech

Peyman Gifani(Founder)in

Co-investorsManta Ray VenturesMartlet Capital

Allfocal Optics develops nanophotonic display technology based on research from Cambridge University, aimed at improving visual clarity and comfort.

Deep TechHardwareSemiconductorsCambridge, GB

Dr. Pawan Shrestha(Founder)in

Co-investors7percent VenturesMartlet Capital

AMR Bio is a clinical-stage biotechnology company developing novel anti-infectives, with a focus on infection prevention.

BiotechHealthtech

Axol Bioscience manufactures human induced pluripotent stem cell (iPSC)-derived cells and provides laboratory services including iPSC banking, reprogramming, gene editing, and cell manufacturing for preclinical drug discovery and disease modeling.

BiotechDeep TechHealthtech

Co-investorsCambridge Angels groupMartlet Capital

Cambridge GaN Devices (CGD) designs ICeGaN gallium nitride power transistors that integrate temperature control and gate reliability features and can be driven by standard silicon gate drivers.

Deep TechHardwareSemiconductors

Fabio Necco(CEO)

Co-investorsCambridge Innovation CapitalIQ CapitalMartlet CapitalBritish Patient Capital

Co-investorsAtlantic Bridge VenturesSony Ventures CorporationSupernova Invest

Cambridge Nutraceuticals develops health supplements based on scientific research, aimed at supporting longer and healthier lives.

ConsumerLongevityWellness & Fitness

Co-investorsMartlet Capital

Camstent develops a patented Bacteriaphobic (bacteria-repelling), non-eluting polymer coating for silicon-based medical devices such as Foley catheters, endotracheal tubes, chest drain tubes, and cannulas.

HealthtechMedical DevicesNew Materials

Co-investorsCambridge Angels groupMartlet Capital

Converge builds concrete monitoring and management tools for construction contractors, including embedded and reusable long-range sensors and AI-powered mix insights under its ConcreteDNA suite.

Advanced ManufacturingAI & Machine LearningConstruction TechIoTLondon, GB

Raph Scheps(CEO)inGideon Farrell(CTO)inRaphael Scheps(Founder)

Co-investorsCambridge Angels groupClimate InvestmentEntrepreneur FirstJ-ImpactMartlet Capital

Deeptech Labs is a venture capital fund and accelerator that invests £100k–£350k in post-seed and seed-stage deeptech startups and runs a structured multi-week program ending in a Demo Day.

Deep TechCambridge, GB

Co-investorsARMCambridge Innovation Capital

DeepTech Recycling develops a patented chemical recycling technology platform that converts complex, hard-to-recycle plastics into base chemicals, monomers, feedstock, and other high-value products.

Circular EconomyCleantechNew Materials

Genetic testing platform for complex diagnostic workflows from patient sampling to result

Dogtooth develops commercial robotic harvesting systems for fruit growers, using on-board 360-degree imaging to pick berries and inspect them for mass, ripeness, and defects.

AgTechAI & Machine LearningRobotics

Co-investors24 HaymarketMartlet Capital

Echion Technologies is a battery technology company that develops and commercialises XNO®, a niobium-based fast-charging battery anode material supplied to cell manufacturers worldwide.

CleantechDeep TechEnergyNew Materials

Jean de la Verpillière(CEO & Co-founder)Alex Groombridge(CTO & Co-founder)Ben Ting(Chief Commercial Officer)Sarah Stevenson(Chief Operating Officer)Ceri Neal(Chief Financial Officer)

Co-investorsKima VenturesMartlet CapitalVolta Energy Technologies

EpiBone engineers bone tissue from stem cells for regenerative medicine and clinical reconstruction, serving patients requiring bone grafts or craniofacial repair.

BiotechHealthtechMedical DevicesNew York, US

Nina Tandon(Co-Founder, CEO)Sarindr Bhumiratana(Co-Founder)Gordana Vunjak-Novakovic(Director)Elma Hawkins(Director)

BoardRobert Langer(Director)David Zhu(Director)in

Co-investorsBeresford VenturesHackensack Meridian Health Bear's DenKendall Capital PartnersPlum Alley InvestmentsTachyon VenturesTech Council Ventures

Exonate is a biotechnology company developing treatments for retinal vascular diseases, with a lead asset (EXN407) intended as a topical therapy for diabetic retinopathy and diabetic macular oedema.

BiotechDigital HealthHealthtechMedical Devices

Olav Hellebø(Chief Executive Officer)

Co-investorsO2h VenturesWellcome TrustWren CapitalCambridge Angels groupMartlet CapitalStoic VC+1 more

FocalPoint develops S-GNSS and Supercorrelation software that improves the accuracy and reliability of standard GNSS receivers using physics and machine learning, without additional hardware.

AI & Machine LearningDeep TechMobility & Transportation

Co-investorsCambridge Angels groupMartlet CapitalMolten VenturesIQ Capital

Medical technology company developing diagnostics for Functional Gastrointestinal Disorders

Mountain View, US

Steve Axelrod(Executive Officer, Director, Promoter)David Kim(Director)

Glycotest develops diagnostic tests for the early detection of liver disease and liver cancer.

BiotechDigital HealthHealthtechMedical DevicesMerion Station, US

Charles Swindell(Executive Officer, Director)

BoardIlian Iliev(Director)inEd Hooper(Director)inJenny Jiang(Director)

Co-investorsFosun Pharma

Mindler (previously ieso) provides one-to-one, therapist-delivered text-based cognitive behavioural therapy (CBT) delivered online to patients, using de-identified therapy data and analysis to inform treatment.

Digital HealthHealthtechMental Health

Co-investorsCambridge Angels groupMartlet CapitalMolten Ventures

Infinitopes develops immunotherapy treatments for cancer, focusing on immune-oncology and antigen discovery solutions aimed at improving patient outcomes and affordability in cancer care.

AI & Machine LearningBiotechHealthtechMedical DevicesOxford, GB

Jonathan Kwok(Co-Founder, President & Chief Medical Officer)inLian Ni Lee(VP Preclinical & Co-Founder)in

Co-investorsAmplify PartnersManta Ray VenturesOctopus VenturesKindred CapitalMartlet Capital

Kalium Health is developing personalised, at-home health monitoring for chronic kidney disease, aimed at helping healthcare providers and patients track key risks to improve outcomes and reduce costs.

Digital HealthHealthtechMedical DevicesCambridge, GB

Fiona Karet(Chief Medical Officer)

Co-investorsMartlet CapitalCambridge Angels group

Myrtle.ai develops low latency AI inference products, including its VOLLO inference accelerator, that run machine learning models in microseconds.

AI & Machine LearningFintechHardware

Co-investorsMartlet CapitalNew Science VenturesIQ Capital

NoBACZ Healthcare develops antibiotic-free, patented liquid barrier products for wound and lesion management, creating waterproof physical barriers that block microbes as an alternative to topical antimicrobials.

AgTechBiotechHealthtechNew Materials

Co-investorsAdjuvoCambridge Angels groupMartlet CapitalThe Yield Lab EuropeThe Yield Lab

Nu Quantum develops quantum networking solutions to enable commercial quantum computer scaling.

Deep TechHardwareQuantum ComputingCambridge, GB

Dr. Carmen Palacios-Berraquero(Founder and CEO)Carmen Palacios-Berraquero(Founder)in

Co-investors7percent VenturesAhren Innovation CapitalAmadeus Capital PartnersExpeditionsIQ CapitalMartlet Capital+4 more

NunaBio manufactures high-complexity DNA constructs from challenging sequences up to production-scale volumes using a modular, cell-free "DNA micro-foundry" platform.

BiotechDeep TechHardwareNew Materials

Co-investorsMartlet CapitalMaven Capital PartnersNorthstar Ventures

OctaiPipe offers a collaborative AI platform that optimises data centre cooling to cut cooling energy use by up to 30% and reduce total building energy costs.

AI & Machine LearningCleantechEnergyEnterprise SoftwareIoT

Co-investorsDouble DownMartlet CapitalMolten VenturesMomenta VenturesSuperSeed

Targeted radiopharmaceutical cancer treatment company

Oxford Space Systems designs and manufactures deployable antennas for satellites, focused on reducing mass and improving stowage efficiency and performance.

Deep TechHardwareSpace TechHarwell, GB

Sean Sutcliffein

Co-investorsCambridge Angels groupFuture Planet CapitalLongwall Venture Partners LLPMartlet CapitalOxford Investment Opportunity NetworkOxford Investment Opportunity Network (OION)+4 more

Paragraf develops graphene-based electronic devices, including molecular sensors (electrolyte-gated field-effect transistors) for biosensing and chemical sensing, and Hall effect sensors for current, position, and magnetic field measurement at cryogenic temperatures.

Deep TechNew MaterialsSemiconductorsCambridgeshire

Simon Thomas(Chief Executive Officer of the issuer.)

Co-investorsAmadeus Capital PartnersBlack Opal VenturesCambridge Angels groupIn-Q-TelIQ CapitalMartlet Capital+4 more

PatientSource is a cloud-based, modular electronic patient record (EPR/EMR) system built by clinicians for hospitals, clinics and departments.

Digital HealthHealthtechSaaS

Co-investorsCambridge Angels group

Pencil Biosciences develops a fully synthetic, modular, non-CRISPR gene editing platform that edits DNA without causing a break or nick.

BiotechDeep TechHealthtech

Co-investorsFuture Planet CapitalMartlet CapitalNorthern GritstoneOctopus VenturesUK Innovation & Science Seed Fund

Pervasid develops TrackMaster, a fixed ceiling-mounted passive RFID reader system that provides real-time, item-level inventory visibility with over 98% accuracy and no manual scanning.

HardwareIoTRetail Tech

Co-investorsMartlet CapitalStanley Ventures

PharmEnable is a small molecule drug discovery company that uses AI to access novel chemical spaces and target proteins that are difficult to drug with traditional approaches.

AI & Machine LearningBiotechDeep Tech

Plastometrex develops materials-testing instruments based on its proprietary Profilometry-based Indentation Plastometry (PIP), which extracts stress-strain curves from indentation data using inverse finite element analysis.

Deep TechHardwareNew Materials

Co-investorsMartlet Capital

Plumis manufactures Automist, a water mist fire suppression system that connects to the standard water supply and uses wall-mounted nozzles to suppress fires with less water than sprinklers.

Construction TechHardwarePropTech

Co-investorsCambridge Angels group

PointGrab makes AI-powered ceiling sensors that detect presence, count people, and track space utilization without cameras or personal data collection, delivering occupancy data for workplace management.

AI & Machine LearningIoTPropTech

Co-investorsEcoMachines Ventures

Porotech develops MicroLED display technology, offering components and technology consultancy through partnerships and R&D.

Deep TechHardwareSemiconductors

Co-investorsIQ Capital

ProAxsis develops active protease biomarker assays and a point-of-use test based on its patented ProteaseTag technology, along with specialist sample testing and scientific collaboration services.

BiotechDigital HealthMedical Devices

Psyomics builds behavioral health assessment tools, including beseen™, which captures structured data and free text from patients, families, and professionals to support clinical pathways for adults and young people.

Digital HealthHealthtechMental Health

Dr. Melinda Rees(Chief Executive Officer)inRupert Hipwell(Chief Commercial Officer)inAlex Nancekievill(Chief Technology Officer)in

Co-investorsCambridge Angels groupMartlet Capital

Q-Bot installs underfloor insulation beneath suspended timber or concrete floors, applying closed-cell foam either robotically or by hand to reduce heat loss and draughts.

CleantechPropTechRobotics

Co-investors2050 CapitalAdjuvoEcoMachines VenturesFoundamental

Qkine manufactures animal-free recombinant bioactive proteins, including growth factors, cytokines, biomarkers, and attachment factors, for stem cell, organoid, and cell culture research.

BiotechDeep TechCambridge, GB

Co-investorsCambridge Angels groupMartlet CapitalOxford Investment Opportunity Network (OION)

Brain and neurological disease diagnosis company

Cellulose-based sustainable colorants for fashion, cosmetics, and packaging.

Co-investorsCambridge Angels groupMartlet CapitalSustainable VenturesAda Ventures

RoboK offers SiteLens®, an AI computer vision platform that analyzes existing CCTV footage to detect workplace hazards, monitor PPE compliance, identify near misses, and generate safety KPI and compliance reports.

Advanced ManufacturingAI & Machine LearningLogistics & Supply Chain

Co-investorsCambridge Angels groupMartlet Capital

Medical technology company founded to address global climate crisis through healthcare innovation

Semarion is an advanced materials engineering company that makes SemaCyte microcarriers — barcoded, microfabricated micro-wells that turn adherent cells into assay-ready reagents compatible with automated 384-well liquid-handling workflows.

BiotechDeep TechNew Materials

Co-investorsMartlet Capital

Signaloid develops UxHw technology, a compute platform that propagates uncertainty by evaluating a distribution of inputs in a single program execution to produce distribution-based results.

AI & Machine LearningDeep TechHardwareSemiconductors

Phillip(Founder, CEO/CTO)

Co-investorsCambridge Angels groupIQ CapitalMartlet CapitalType One Ventures

Sofant develops satellite communication terminal technology, including RF MEMS beamforming phased array antennas, optimized for size, weight, power consumption and cost.

Deep TechHardwareSpace Tech

Co-investorsKelvin CapitalSeraphim SpaceShibumi InternationalScottish Enterprise

Sorex Sensors develops sensors based on film bulk acoustic resonator (FBAR) technology for indoor air quality monitoring, detecting toxic particulates and volatile organic compounds in the sub-PM2.5 range.

Deep TechHardwareIoT

Co-investorsCambridge Angels groupMartlet Capital

Spotta builds IoT-based pest detection systems that automatically monitor for insects such as bed bugs, red palm weevil, and forestry pests.

AgTechAI & Machine LearningHardwareIoTCambridge, GB

Robert Fryers(Founder & CEO)inNeil D'Souza-Mathew(Founder & CTO)inRob Alner(COO)inMike Payne(Finance Director)

Co-investorsBayes Entrepreneurship FundCambridge Angels groupMartlet CapitalREMUS CapitalThe Yield Lab EuropeThe Yield Lab

Strolll offers an augmented reality platform for neurological rehabilitation, providing gait training, rehab exercises, and assessments in one system.

Digital HealthHealthtechMedical Devices

Tom Finn(Founder)in

Co-investorsFuture Planet CapitalIW CapitalKluz VenturesMartlet Capital

Techspert provides an expert-sourcing platform for market research teams in life sciences and healthcare, using in-house search technology to find vetted specialists for quantitative and qualitative studies.

AI & Machine LearningB2B MarketplacesHealthtechSaaS

Dave Holden(CEO & Co-Founder)Chris Musgrove(CFO)Jamie Beard(COO)

Co-investorsWestern Technology Investment

TransparentChoice provides a project portfolio prioritization system combining a criteria-based decision framework, a portfolio management platform, and expert PMO advisory support.

Enterprise SoftwareSaaS

Co-investorsCambridge Angels groupMartlet Capital

Tripism is a platform for corporate travel teams to communicate travel program information and engage with business travelers, replacing outdated travel intranets.

Enterprise SoftwareSaaSTravel & HospitalityCambridge, GB

Adam Kerr(Founder)

Co-investorsMartlet Capital

Benchtop solution for label-free, sample preparation-free isolation and purification

Intelligent platform for Remote Patient Monitoring and Virtual Care

Xampla is a materials innovation company that develops Morro plant-based polymer materials as biodegradable, home-compostable alternatives to polluting plastics.

Circular EconomyDeep TechNew MaterialsCambridge, GB

Tuomas Knowles(Professor / Founder)Marc Rodriguez(CTO)Marc Rodríguez Garciain

Co-investorsAmadeus Capital PartnersAvonmore DevelopmentsCambridge Angels groupEmerald Technology Ventures AgHorizons VenturesMartlet Capital+3 more